Virology, Nebraska Center for

 

Document Type

Article

Date of this Version

2015

Citation

Int J Cancer. 2015 March 1; 136(5): 1241–1242.

Comments

Copyright 2015 John Wiley. Used by permission.

Abstract

With great interest, we read the recent publication “Kaposi’s sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era” by Bohlius et al. We congratulate the authors for their contribution to this field. In this study the authors observed a decrease in incidence of Kaposi’s sarcoma (KS) in patients treated with anti-retroviral therapy (ART) when compared to patients who are not on ART. These results are encouraging because of the ongoing HIV epidemic in sub-Saharan Africa where KS is still one of the most prevalent cancers. Also, it is a relevant topic to study in South Africa; a country that has a high prevalence of both HIV and Kaposi’s sarcoma-associated herpesvirus (KSHV) infections.

Share

COinS